Autoimmune Diseases And Lymphopenia: Role In Disease Activity
Published on: October 28, 2025
Autoimmune Diseases And Lymphopenia: Role In Disease Activity
Article author photo

Khairat Salisu

Master of Public Health - MPH, Public Health, <a href="https://www.nottingham.ac.uk/" rel="nofollow">University of Nottingham</a>

Article reviewer photo

Aravendan Anandaraaj

MPharm, University of Manchester

Introduction

Autoimmune diseases are conditions where your body’s immune system, which normally fights infections, mistakenly attacks your body’s own cells. This can cause long-lasting inflammation and symptoms such as tiredness, joint pain, rashes, or problems with organs like the kidneys or nerves. Examples include lupus and rheumatoid arthritis.1

Lymphopenia means having fewer lymphocytes than normal in the blood. Lymphocytes are a type of white blood cell that help recognise and control infections and keep the immune response balanced. When their numbers are low, the body may be less able to fight infections and may also struggle to keep inflammation under control.2

Understanding the link between autoimmune diseases and lymphopenia is important, as a low lymphocyte count can reflect disease activity or the effects of treatment on the immune system.

Overview of autoimmune diseases

Autoimmune diseases are a group of conditions that share one key feature: the immune system, which is meant to protect us, turns against the body’s own healthy cells. Instead of fighting only germs such as viruses or bacteria, it mistakenly attacks your joints, skin, glands, or even vital organs.1

Some well-known examples are:3

  • Systemic lupus erythematosus (lupus): Can affect the skin, joints, kidneys, and many other organs
  • Rheumatoid arthritis: Mainly causes painful, swollen joints
  • Multiple sclerosis: Affects the brain and spinal cord, leading to problems with movement, vision, and coordination
  • Sjögren’s syndrome: Often causes dry eyes and dry mouth due to an attack on moisture-producing glands

Although these illnesses affect different parts of the body, they often share common patterns:4

  • They tend to last for years and may go through ups and downs, with flare-ups when symptoms get worse
  • They involve chronic inflammation, meaning the body is in a constant state of high alert
  • They can cause significant tiredness and reduce the quality of life.

In short, autoimmune diseases are long-term conditions where the immune system is out of balance, and this imbalance plays a central role in both symptoms and progression.

Overview of lymphopenia

Lymphopenia is the medical term for having too few lymphocytes in the blood. Lymphocytes are a type of white blood cell that play a central role in the immune system. They help the body recognise germs, produce antibodies, and destroy infected or abnormal cells. Doctors usually detect lymphopenia through a routine blood test called a full blood count. In adults, lymphopenia is often defined as fewer than about 1,000 lymphocytes per microlitre of blood, although the exact threshold may vary.2

There are two main types of lymphocytes

  • T cells: Act as organisers and fighters, helping to direct the immune response and kill infected cells
  • B cells: Produce antibodies, which are proteins that target and neutralise invading germs

When lymphopenia occurs, one or both of these groups may be reduced, weakening the immune system’s balance and effectiveness.

Mechanisms linking lymphopenia to autoimmunity

While the precise cause-and-effect relationship is still being studied, one way low lymphocyte counts (lymphopenia) may worsen autoimmunity is by reducing the number of regulatory T cells (Tregs). These cells normally help prevent the immune system from attacking the body’s own tissues. When their numbers are low, the immune system may lose control and start reacting to healthy cells, leading to autoimmunity.

A second problem is what happens when the immune system tries to rebuild after lymphocytes are lost. To fill the gap, the body encourages the remaining cells to multiply quickly. However, this rushed process can allow cells to slip through without proper safety checks. Some of these replacement cells may be more likely to react against the body’s own tissues, fuelling autoimmune responses.

Finally, some treatments for autoimmune diseases can also lower lymphocyte levels, which adds to the problem. This creates a cycle where the immune system is constantly unbalanced, both from the disease and the medicines used to treat it.6

Role of lymphopenia in disease activity

Lymphopenia may be a sign that an autoimmune disease is active or flaring up. When the immune system is highly active, for example, during a flare, it may use up more lymphocytes or damage them, leading to lower levels in the blood. Some treatments, like strong immunosuppressive drugs, can also reduce lymphocyte numbers.7

Low lymphocyte counts may make it harder for the body to fight infections, but they can also show that the immune system is out of balance. In many autoimmune conditions, a drop in lymphocytes is linked to more severe symptoms or worsening disease.8

Clinical implications

Lymphopenia has practical consequences for how doctors diagnose, monitor, and treat autoimmune diseases.

Diagnosis and monitoring

A simple routine blood test can measure lymphocyte levels. Tracking these counts over time can provide valuable clues about whether the disease is stable, improving, or flaring. Falling numbers may warn of rising disease activity or signal that treatment is suppressing the immune system more than intended.6

Prognosis

If lymphopenia persists over many months, it can be a sign of a poorer outlook. Patients with long-term low lymphocyte counts are more likely to have severe disease, repeated flares, or complications involving major organs.8

Treatment considerations

Doctors must strike a careful balance. Treatments such as immunosuppressants are designed to calm the overactive immune system, but if they reduce lymphocytes too much, patients become vulnerable to infections. On the other hand, if the immune system is not calmed down enough, autoimmunity can continue to damage the body. This means doctors often adjust medication doses or change treatments to keep lymphocyte counts within a safer range.

Overall

Lymphopenia is therefore both a warning sign and a guide. It helps doctors judge whether the immune system is too strong, too weak, or well-balanced, and it influences decisions about treatment and long-term care.

Summary

Autoimmune diseases occur when the immune system mistakenly attacks the body’s own tissues, leading to long-term inflammation and symptoms such as fatigue, joint pain, or organ damage. Common examples include lupus, rheumatoid arthritis, and multiple sclerosis. Lymphopenia refers to a low number of lymphocytes, key white blood cells that regulate immune responses. This condition can weaken the immune system’s ability to control infections and maintain immune balance.

There is a strong link between lymphopenia and autoimmune diseases. Low lymphocyte levels may result from the disease itself, immune system dysregulation, or immunosuppressive treatments. A reduced number of regulatory T cells, for instance, can contribute to autoimmunity by allowing the immune system to attack the body’s own tissues.

Clinically, lymphopenia may serve as an important indicator of disease activity and prognosis. Persistent low lymphocyte counts may often reflect more severe disease and can guide treatment decisions. Monitoring lymphocyte levels may help doctors assess whether treatment is effective or needs adjustment to maintain immune balance while avoiding infection risks. In essence, lymphopenia may be both a consequence and contributor to autoimmune disease and plays a crucial role in diagnosis, monitoring, and management.

References

  1. Samuels H, Malov M, Saha Detroja T, Ben Zaken K, Bloch N, Gal-Tanamy M, et al. Autoimmune disease classification based on pubmed text mining. J Clin Med [Internet]. 2022 Jul 26 [cited 2025 Sep 30];11(15):4345. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369164/
  2. Petramala L, Milito C, Sarlo F, Servello A, Circosta F, Marino L, et al. Clinical impact of transient lymphopenia. Clin Exp Med [Internet]. 2024 Apr 17 [cited 2025 Sep 30];24(1):77. Available from: https://doi.org/10.1007/s10238-024-01340-0
  3. Song Y, Li J, Wu Y. Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders. Sig Transduct Target Ther [Internet]. 2024 Oct 4 [cited 2025 Sep 30];9(1):1–40. Available from: https://www.nature.com/articles/s41392-024-01952-8
  4. National Academies of Sciences E, Division H and M, Practice B on PH and PH, Diseases C for the A of NR on A. Background on autoimmune diseases. In: Enhancing NIH Research on Autoimmune Disease [Internet]. National Academies Press (US); 2022 [cited 2025 Sep 30]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK605884/
  5. Justiz Vaillant AA, Sabir S, Jan A. Physiology, immune response. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Sep 30]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK539801/
  6. Sheu TT, Chiang BL. Lymphopenia, lymphopenia-induced proliferation, and autoimmunity. Int J Mol Sci [Internet]. 2021 Apr 16 [cited 2025 Oct 1];22(8):4152. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073364/
  7. Sapartini G, Ghrahani R, Setiabudiawan B. Lymphopenia as an independent marker of disease activity in children with systemic lupus erythematosus. Children (Basel) [Internet]. 2025 Apr 10 [cited 2025 Oct 1];12(4):486. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12025848/
  8. Goswami TK, Singh M, Dhawan M, Mitra S, Emran TB, Rabaan AA, et al. Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders – Advances and challenges. Hum Vaccin Immunother [Internet]. [cited 2025 Oct 1];18(1):2035117. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009914/
Share

Khairat Salisu

Master of Public Health - MPH, Public Health, University of Nottingham

Khairat is a postgraduate student pursuing a Master of Public Health degree and is strongly committed to advancing public health and improving healthcare outcomes. She holds a BSc (Hons) degree in Biomedical Science, which provides her with a solid foundation in scientific knowledge, research and writing skills.

Khairat is passionate about bridging the gap between complex scientific concepts and accessible health content, advocating for a better understanding of different health conditions. Driven by the potential to make a meaningful impact, she seeks to contribute significantly to medical communication and public health through her research and practice.

arrow-right